Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic
Autor
Ganatra, Sarju
Dani, Sourbha S.
Shah, Sachin
Asnani, Aarti
Neilan, Tomas G.
Lenihan, Daniel
Ky, Bonnie
Barac, Ana
Hayek, Salim S.
Leja, Monika
Herrmann, Joerg
Thavendiranathan, Paaladinesh
Fradley, Michael
Bang, Vigyan
Shreyder, Katherine
Parikh, Rohan
Pate, Rushin
Singh, Amitoj
Brar, Simarjeet
Guha, Avirup
Gupta, Dipti
Mascari, Paolo
Patten, Richard D.
Venesy, David M.
Nohria, Anju
Resnic, Frederic S.
Institución
Resumen
Patients with pre-existing cardiovascular disease and risk factors are more likely to experience adverse
outcomes associated with the novel coronavirus disease-2019 (COVID-19). Additionally, consistent reports
of cardiac injury and de novo cardiac complications, including possible myocarditis, arrhythmia, and heart
failure in patients without prior cardiovascular disease or significant risk factors, are emerging, possibly
due to an accentuated host immune response and cytokine release syndrome. As the spread of the virus
increases exponentially, many patients will require medical care either for COVID-19 related or traditional
cardiovascular issues. While the COVID-19 pandemic is dominating the attention of the healthcare system, there is an unmet need for a standardized approach to deal with COVID-19 associated and other
traditional cardiovascular issues during this period. We provide consensus guidance for the management
of various cardiovascular conditions during the ongoing COVID-19 pandemic with the goal of providing
the best care to all patients and minimizing the risk of exposure to frontline healthcare workers.